Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86364 | Target Info | |||
Target Name | Vasoactive intestinal polypeptide receptor 1 (VIPR1) | ||||
Synonyms | Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor-1; Vasoactive intestinal peptide receptor 1; VPAC1; VPAC-1; VIPR1; VIP-R-1; Pituitary adenylate cyclase activating polypeptide type II receptor; PACAP-R-2; PACAP type II receptor | ||||
Target Type | Clinical trial Target | ||||
Gene Name | VIPR1 | ||||
Biochemical Class | GPCR secretin | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Cholesterol | Ligand Info | |||||
Structure Description | Cryo-EM structure of an activated VIP1 receptor-G protein complex | PDB:6VN7 | ||||
Method | Electron microscopy | Resolution | 3.20 Å | Mutation | No | [1] |
PDB Sequence |
ASLDEQQTMF
138 YGSVKTGYTI148 GYGLSLATLL158 VATAILSLFR168 KLHCTRNYIH178 MHLFISFILR 188 AAAVFIKDLA198 LFDSVGCKAA218 MVFFQYCVMA228 NFFWLLVEGL238 YLYTLLAVSF 248 FSERKYFWGY258 ILIGWGVPST268 FTMVWTIARI278 HFEDYGCWDT288 INSSLWWIIK 298 GPILTSILVN308 FILFICIIRI318 LLQKLRPPPY336 SRLARSTLLL346 IPLFGVHYIM 356 FAFFPDNFKP366 EVKMVFELVV376 GSFQGFVVAI386 LYCFLNGEVQ396 AELRRKWRRW 406 HLQ
|
|||||
|
HIS180
3.361
ILE183
3.967
LEU187
3.704
SER212
4.162
VAL213
3.806
LYS216
4.445
ALA217
3.723
VAL220
4.369
PHE221
3.672
TYR224
3.572
PHE255
4.884
TRP256
4.608
ILE259
4.004
LEU260
3.939
TRP263
3.626
GLY264
3.811
SER267
3.386
PHE269
3.676
THR270
4.642
MET271
3.765
THR274
4.342
ILE278
3.616
TRP286
4.558
SER291
4.724
SER292
2.792
TRP295
3.362
ILE296
3.754
GLY299
4.880
PRO300
4.021
THR303
3.745
PHE309
4.989
PHE312
4.213
ILE313
3.759
ILE316
3.769
ARG317
3.822
LEU320
3.703
THR343
4.527
VAL352
4.951
ILE355
3.344
MET356
3.887
PHE359
4.007
PHE360
3.759
PRO361
3.739
PHE364
3.941
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy. Nat Commun. 2020 Aug 17;11(1):4121. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.